J. Bougie

Assessment in Work Productivity and the Relationship with Cognitive Symptoms (AtWoRC): primary analysis from a Canadian open-label study of vortioxetine in patients with major depressive disorder (MDD)

E. Rampakakis, P. Chokka, J. Proulx, 2018, CNS Spectrums.

Long-term functioning outcomes are predicted by cognitive symptoms in working patients with major depressive disorder treated with vortioxetine: results from the AtWoRC study

P. Chokka, J. Proulx, A. Ettrup, 2019, CNS Spectrums.

Improvements in Workplace Productivity in Working Patients with Major Depressive Disorder: Results from the AtWoRC Study.

P. Chokka, A. Ettrup, G. Clerzius, 2019, Journal of occupational and environmental medicine.

Real-life assessment of aripiprazole monthly (Abilify Maintena) in schizophrenia: a Canadian naturalistic non-interventional prospective cohort study

A. Malla, E. Rampakakis, J. Proulx, 2019, BMC Psychiatry.

Anxiety symptoms in working patients with major depressive disorder treated with vortioxetine: associations with clinical and treatment outcomes in the AtWoRC study

P. Chokka, A. Ettrup, G. Clerzius, 2021, Therapeutic advances in psychopharmacology.

Canadian economic impact of improved workplace productivity in patients with major depressive disorder treated with vortioxetine

C. Beauchemin, J. Lachaine, P. Chokka, 2018, CNS Spectrums.

Long-term functioning outcomes are predicted by cognitive symptoms in working patients with major depressive disorder treated with vortioxetine: results from the AtWoRC study

P. Chokka, J. Proulx, A. Ettrup, 2019, CNS Spectrums.

Canadian economic impact of improved workplace productivity in patients with major depressive disorder treated with vortioxetine

C. Beauchemin, J. Lachaine, P. Chokka, 2019, CNS Spectrums.